Finra updates and enhances Fund Analyzer tool

Advisers and investors will get better look at costs in 30,000 products
NOV 21, 2017

The Financial Industry Regulatory Authority Inc. has updated its Fund Analyzer tool, which is designed to help investors and financial professionals understand the fees and discounts available on mutual funds, exchange-traded funds, exchange-traded notes and money market funds. Finra said the updated tool — which allows for the comparison of more than 30,000 products on the basis of fees, expenses and discounts — includes features that allow it to model investor behaviors and to illustrate the impact that wrap accounts and flat fees can have on overall costs and future account values. Users may select up to three funds at a time to compare. After they input the amount of money they plan to invest and how long they plan to keep the fund, the Fund Analyzer performs the calculations. In the coming months, Finra will add instructional videos to help investors better understand the new, more advanced features and data analyses functions. Finra said the earlier version of the tool will be available on its website until February 1.

Latest News

Retirement plan defaults leave key participant decisions unresolved
Retirement plan defaults leave key participant decisions unresolved

New Allspring research finds 401(k) participants want guidance on income and rollovers, not just portfolio automation.

Global equity release market set to triple, with US leading growth
Global equity release market set to triple, with US leading growth

Aging homeowners hold record housing wealth - but most advisors still aren't bringing it into retirement plans

Retiree alleges advisor withheld $600K through real estate LLC web
Retiree alleges advisor withheld $600K through real estate LLC web

$1.7M invested from an inheritance. Then the phone went dead.

SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception
SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception

The pre-IPO platform sold $430M in units while allegedly rigging prices behind the scenes.

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor